UBS Group AG - ARIDIS PHARMACEUTICALS INC ownership

ARIDIS PHARMACEUTICALS INC's ticker is ARDS and the CUSIP is 040334104. A total of 19 filers reported holding ARIDIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ARIDIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$842
-90.7%
2,683
-65.0%
0.00%
Q4 2022$9,048
+201.6%
7,668
+139.8%
0.00%
Q3 2022$3,000
-66.7%
3,197
-61.4%
0.00%
Q2 2022$9,000
-62.5%
8,293
+156.8%
0.00%
Q2 2021$24,000
+700.0%
3,229
+611.2%
0.00%
Q4 2020$3,000
-25.0%
454
-22.4%
0.00%
Q3 2020$4,000
-55.6%
585
-56.6%
0.00%
Q2 2020$9,000
+200.0%
1,349
+83.8%
0.00%
Q4 2019$3,000
-57.1%
734
-28.4%
0.00%
Q3 2019$7,000
-66.7%
1,025
-50.3%
0.00%
Q2 2019$21,000
+10.5%
2,063
+25.0%
0.00%
Q1 2019$19,000
-13.6%
1,651
-18.5%
0.00%
Q4 2018$22,000
-8.3%
2,026
+12.0%
0.00%
Q3 2018$24,0001,8090.00%
Other shareholders
ARIDIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Wealth Architects, LLC 14,077$1,4370.00%
View complete list of ARIDIS PHARMACEUTICALS INC shareholders